All Stories

  1. A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes (T1D)

    Article • Endocrine Connections, April 2017, Bioscientifica

    Professor Peter E Clayton

  2. Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2017, Endocrine Society

    Prof Jean-Claude Carel, Professor Lars Sävendahl, Professor Peter E Clayton

  3. Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study

    Article • European Journal of Endocrinology, September 2016, Bioscientifica

    Professor Peter E Clayton

  4. GH deficiency status combined with GH receptor polymorphism affects response to GH in children

    Article • September 2015, Bioscientifica

    Professor Peter E Clayton

  5. 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years

    Article • June 2015, Bioscientifica

    Professor Peter E Clayton

  6. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults

    Article • February 2015, Bioscientifica

    Professor Peter E Clayton, Professor Gudmundur Johannsson

  7. 3-M syndrome: a growth disorder associated with IGF2 silencing

    Article • October 2013, Bioscientifica

    Professor Peter E Clayton

  8. A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome

    Article • June 2013, Bioscientifica

    Professor Peter E Clayton

  9. Metformin in Obese Children with Abnormal Glucose and Insulin Status

    Article • January 2013, Springer Science + Business Media

    Professor Peter E Clayton

  10. Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling

    Article • September 2012, Bioscientifica

    Professor Peter E Clayton